HSBC Holdings’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-6,225
| Closed | -$1.35M | – | 3170 |
|
|
2021
Q1 | $1.35M | Hold |
6,225
| – | – | ﹤0.01% | 1461 |
|
|
2020
Q4 | $711K | Hold |
6,225
| – | – | ﹤0.01% | 1945 |
|
|
2020
Q3 | $610K | Sell |
6,225
-21,000
| -77% | -$2.42M | ﹤0.01% | 1814 |
|
|
2020
Q2 | $3.34M | Hold |
27,225
| – | – | 0.01% | 998 |
|
|
2020
Q1 | $2.35M | Hold |
27,225
| – | – | 0.01% | 1105 |
|
|
2019
Q4 | $2.85M | Sell |
27,225
-27,224
| -50% | -$3.05M | 0.01% | 1359 |
|
|
2019
Q3 | $6.26M | Hold |
54,449
| – | – | 0.01% | 1085 |
|
|
2019
Q2 | $9.39M | Buy |
+54,449
| New | +$9.42M | 0.02% | 859 |
|
|
2019
Q1 | – | Sell |
-53,388
| Closed | -$5.2M | – | 2952 |
|
|
2018
Q4 | $5.2M | Sell |
53,388
-1,061
| -2% | -$139K | 0.01% | 1092 |
|
|
2018
Q3 | $9.41M | Hold |
54,449
| – | – | 0.02% | 877 |
|
|
2018
Q2 | $7.6M | Buy |
54,449
+27,224
| +100% | +$3.87M | 0.01% | 932 |
|
|
2018
Q1 | $3.07M | Sell |
27,225
-27,224
| -50% | -$3.42M | ﹤0.01% | 1284 |
|
|
2017
Q4 | $7.19M | Buy |
54,449
+52,224
| +2,347% | +$6.14M | 0.01% | 761 |
|
|
2017
Q3 | $226K | Sell |
2,225
-25,000
| -92% | -$2.68M | ﹤0.01% | 2092 |
|
|
2017
Q2 | $2.73M | Hold |
27,225
| – | – | 0.01% | 1173 |
|
|
2017
Q1 | $3.29M | Sell |
27,225
-4
| -0% | -$491 | 0.01% | 1075 |
|
|
2016
Q4 | $3.04M | Buy |
+27,229
| New | +$3.28M | 0.01% | 1102 |
|
|
2015
Q4 | – | Sell |
-4,380
| Closed | -$400K | – | 2285 |
|
|
2015
Q3 | $400K | Buy |
+4,380
| New | +$487K | ﹤0.01% | 1492 |
|
Other funds holding GWPH
HSBC Holdings's GWPH Position: Q2 2021 in Review
HSBC Holdings sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 6,225 shares — an estimated $1.35M sold.
HSBC Holdings first reported a position in GWPH in Q3 2015 and held it in 18 quarters. The position peaked at $9.41M in Q3 2018. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- HSBC Holdings reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- HSBC Holdings sold 6,225 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1.35M.
- HSBC Holdings first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2015 and held it in 18 quarters.
- HSBC Holdings's GW Pharmaceuticals Plc American Depositary Shares position peaked at $9.41M in Q3 2018.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on HSBC Holdings's 13F filing for Q2 2021, filed 13 Aug 2021.